Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Current Molecular Medicine
|
August 18, 2023
Physicochemical Stimulus-Responsive Systems Targeted with Antibody Derivatives
Rezvan Mohammadi, Sepideh Ghani, Roghaye Arezumand, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
June 25, 2020
Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccine
Maryam Esmaily, Ali Masjedi, Shahin Hallaj, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
June 20, 2020
Silencing adenosine A2a receptor enhances dendritic cell-based cancer immunotherapy
Ali Masjedi, Armin Ahmadi, Sepideh Ghani, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
November 8, 2021
Gene regulation by antisense transcription: A focus on neurological and cancer diseases
Sajad Najafi, Shing Cheng Tan, Pourya Raee, et al.
Pharmaceutical Research
|
September 18, 2020
Codelivery of HIF-1α siRNA and Dinaciclib by Carboxylated Graphene Oxide-Trimethyl Chitosan-Hyaluronate Nanoparticles Significantly Suppresses Cancer Cell Progression
Sepideh Izadi, Asma Moslehi, Hadiseh Kheiry, et al.
Journal of Cellular Physiology
|
June 4, 2020
Concomitant blockade of A2AR and CTLA-4 by siRNA-loaded polyethylene glycol-chitosan-alginate nanoparticles synergistically enhances antitumor T-cell responses
Mitra Ghasemi-Chaleshtari, Seyed Hossein Kiaie, Mahzad Irandoust, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Current Molecular Medicine
|
August 18, 2023
Physicochemical Stimulus-Responsive Systems Targeted with Antibody Derivatives
Rezvan Mohammadi, Sepideh Ghani, Roghaye Arezumand, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
June 25, 2020
Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccine
Maryam Esmaily, Ali Masjedi, Shahin Hallaj, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
June 20, 2020
Silencing adenosine A2a receptor enhances dendritic cell-based cancer immunotherapy
Ali Masjedi, Armin Ahmadi, Sepideh Ghani, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
November 8, 2021
Gene regulation by antisense transcription: A focus on neurological and cancer diseases
Sajad Najafi, Shing Cheng Tan, Pourya Raee, et al.
Pharmaceutical Research
|
September 18, 2020
Codelivery of HIF-1α siRNA and Dinaciclib by Carboxylated Graphene Oxide-Trimethyl Chitosan-Hyaluronate Nanoparticles Significantly Suppresses Cancer Cell Progression
Sepideh Izadi, Asma Moslehi, Hadiseh Kheiry, et al.
Journal of Cellular Physiology
|
June 4, 2020
Concomitant blockade of A2AR and CTLA-4 by siRNA-loaded polyethylene glycol-chitosan-alginate nanoparticles synergistically enhances antitumor T-cell responses
Mitra Ghasemi-Chaleshtari, Seyed Hossein Kiaie, Mahzad Irandoust, et al.
Page
of 2